3 hours ago
6
More than one-quarter of people with Type 2 diabetes now use GLP-1 receptor agonists, a class of medications that includes Ozempic. But new research from Stanford Medicine and international collaborators suggests these widely prescribed drugs may be less effective for some patients because of their genetics.
The study found that about 10% of people carry genetic variants linked to a phenomenon known as GLP-1 resistance. Individuals with these variants appear t...
English (US) ·